Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 761 - 768 of 11617 results
Unlocking Canada's Legal Sector for the Next Generation of Laywers
December 28, 2023| Article| Viewpoint
Three Trends in AI Regulation in 2023 — AI: The Washington Report
December 27, 2023| Article| Viewpoint
Telephone and Texting Compliance News — December 2023
December 27, 2023| Article| Viewpoint
Telephone and Texting Compliance News: Regulatory Update — Commission Adopts Second Report and Order On Robotexting With Some Changes
December 27, 2023| Article| Viewpoint
Telephone and Texting Compliance News: Litigation Update — Two Courts Agree With Defendant’s Challenges to Imprecise TCPA Class Definitions
December 27, 2023| Article| Viewpoint
New Merger Enforcement Toolkit: FTC and DOJ Release Final 2023 Merger Guidelines
December 27, 2023| Blog| Viewpoint
USCIS Announces Premium Processing Fee Increase Effective February 26, 2024
December 27, 2023| Alert| Viewpoint
ADA “Tester” Standing Case Evades US Supreme Court Review—For Now
December 26, 2023| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.